Claude Science is Anthropic’s newest flagship product

2026-06-30 · Source: MIT Technology Review · Field: Science & Research — Life Sciences & Biology, Health & Medical Research, Research Methodology & Innovation · Depth: Intermediate, short

Summary

Anthropic has launched Claude Science, a new flagship product designed to support scientific research, mirroring Claude Code's role in software engineering. Announced at an event for pharmaceutical executives and researchers, Claude Science is now available to all paid Claude subscribers. This standalone product can autonomously perform complex tasks with high-level instructions and includes tools beneficial for computational biology and drug development. Anthropic views Claude Science as a critical offering, elevating it alongside Claude Code and Claude Cowork. The company also revealed plans to use Claude Science for its own research into drugs for rare, neglected diseases. This move positions Anthropic to potentially take a leading role in AI for science, especially with former DeepMind researcher John Jumper joining, and aims to enhance scientific productivity by assisting with coding and managing powerful computer clusters while prioritizing reproducibility.

Key takeaway

For research scientists or biotech founders evaluating AI tools for drug discovery or computational biology, Claude Science offers a significant new option. You should explore its capabilities for autonomously identifying drug candidates and managing complex computational tasks. Its emphasis on reproducibility can streamline your validation processes. Consider integrating it into your workflow, especially if your research involves genetics, chemistry, or protein biology. This could accelerate project timelines and enhance your team's productivity.

Key insights

Anthropic's Claude Science is a new standalone AI product designed to autonomously accelerate scientific research, particularly in drug development and computational biology.

Principles

• AI agents can perform useful, independent scientific work.
• Reproducibility is key for AI tools in science.
• Life sciences offer the greatest AI opportunity.

In practice

• Identify new drug candidates for genetic diseases.
• Run scientific code on powerful computer clusters.
• Trace figure/result sources for accuracy checks.

Topics

• Claude Science
• Anthropic
• Drug Discovery
• Computational Biology
• AI for Science
• Large Language Models
• Reproducibility

Best for: Research Scientist, Domain Expert, AI Scientist

Related on AIssential

• Anthropic Runs Pre-Clinical Drug Trials, Launches Sonnet 5 Model — Anthropic is expanding its AI applications into biology research and drug development.
• Anthropic’s Claude Science bets on workflow, not a new model, to win over scientists — Anthropic's Claude Science prioritizes workflow integration and reproducibility for scientists over new model development, aiming to own the operating layer.
• Claude Just Broke Bioinformatics — Anthropic's new plugin marketplace integrates bioinformatics tools directly into Claude Code, streamlining research workflows.
• Anthropic just launched Claude Design, an AI tool that turns prompts into prototypes and challenges Figma — Anthropic's Claude Design enables AI-driven prototyping from natural language, expanding its ecosystem and challenging traditional design tools.
• Anthropic Releases Claude Science for Automating Research — Claude Science is Anthropic's new offering designed to automate various aspects of scientific research.
• 🗞️ Viral leaked screenshots shows Anthropic built a Lovable competitor into Claude — AI is evolving towards integrated platforms, efficient multi-agent systems, and advanced security exploitation capabilities.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by MIT Technology Review.